Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?

Journal of Diabetes Research
Matthias Ploug Larsen, Signe Sørensen Torekov

Abstract

The incretin effect is impaired in patients with type 2 diabetes. To assess the relation between the incretin hormone GLP-1 and the prediabetic subtypes: impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and the combined IFG/IGT to investigate whether a low GLP-1 response may be a predictor of prediabetes in adults. 298 articles were found using a broad search phrase on the PubMed database and after the assessment of titles and abstracts 19 articles were included. Studies assessing i-IFG/IFG and i-IGT/IGT found both increased, unaltered, and reduced GLP-1 levels. Studies assessing IFG/IGT found unaltered or reduced GLP-1 levels. When assessing the five studies with the largest sample size, it clearly suggests a decreased GLP-1 response in IFG/IGT subjects. Several other factors (BMI, glucagon, age, and nonesterified fatty acids (NEFA)), including medications (metformin), may also influence the secretion of GLP-1. This review suggests that the GLP-1 response is a variable in prediabetes possibly due to a varying GLP-1-secreting profile during the development and progression of type 2 diabetes or difference in the measurement technique. Longitudinal prospective studies are needed to assess whether a reduced GLP-1 ...Continue Reading

References

Jan 1, 1986·Diabetologia·M NauckW Creutzfeldt
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·M B Toft-NielsenJ J Holst
Aug 28, 2001·Diabetes Care·E RaskUNKNOWN Northern Sweden Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA)
Oct 12, 2007·Physiological Reviews·Jens Juul Holst
Sep 27, 2008·Endocrinology·Gareth E LimPatricia L Brubaker
Sep 15, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Carolyn F Deacon, Jens J Holst
Jun 16, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·L PalaC M Rotella
Nov 18, 2011·The Journal of Clinical Endocrinology and Metabolism·Galina SmushkinAdrian Vella
Jan 21, 2012·The Review of Diabetic Studies : RDS·Carolyn F Deacon, Bo Ahrén
Aug 30, 2013·American Journal of Physiology. Cell Physiology·Camilla KappeAke Sjöholm
Dec 11, 2013·Archives of Medical Research·Magda S HusseinRasha Ibrahim
Dec 18, 2013·Journal of Diabetes and Its Complications·Leigh Perreault, Kristine Færch
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Jan 17, 2015·Indian Journal of Endocrinology and Metabolism·Awadhesh Kumar Singh
Aug 14, 2015·Endocrinology·Jeffrey GagnonPatricia L Brubaker
Mar 16, 2016·European Journal of Endocrinology·Eva W IepsenSigne S Torekov
May 1, 2017·The Lancet. Diabetes & Endocrinology·Christian BommerSebastian Vollmer

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.